Abstract
Cancer is a major cause of death worldwide, resulting from the uncontrolled growth of abnormal cells in the body. Cells are the body’s building blocks, and cancer starts from normal cells. Normal cells divide to grow in order to maintain cell population equilibrium, balancing cell death. Cancer occurs when unbounded growth of cells in the body happens fast. It can also occur when cells lose their ability to die. There are many different kinds of cancers, which can develop in almost any organ or tissue, such as lung, colon, breast, skin, bones, or nerve tissue. There are many known causes of cancers that have been documented to date including exposure to chemicals, drinking excess alcohol, excessive sunlight exposure, and genetic differences, to name a few [38]. However, the cause of many cancers still remains unknown. The most common cause of cancer-related death is lung cancer. Some cancers are more common in certain parts of the world. For example, in Japan, there are many cases of stomach cancer, but in the USA, this type of cancer is pretty rare [49]. Differences in diet may play a role. Another hypothesis is that these different populations could have different genetic backgrounds predisposing them to cancer. Some cancers also prey on individuals who are either missing or have altered genes as compared to the mainstream population. Unfortunately, treatment of cancer is still in its infancy, although there are some successes when the cancer is detected early enough. To begin to address these important issues, in this work we will focus solely on genetic issues related to cancer so that we can explore a new treatment area known as gene therapy as a viable approach to treatment of cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adam, J.A., Bellomo, N.: A Survey of Models for tumor-immune system dynamics, Birkhauser Series on Modeling and Simulation in Science, Engineering and Technology. Birkhauser, Boston (1997)
Aguda, B.D., Kim, Y., Piper-Hunter, M.G., Friedman, A., Marsh, C.: MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F and Myc. Proc. Natl. Acad. Sci. USA 105, 19678–19683 (2008)
Ambrosi, D., Bellomo, N., Preziosi, L.: Modelling tumor progression, heterogeneity, and immune competition. J. Theor. Med. 4, 51–65 (2002)
Andasari, V., Gerisch, A., Lolas, G., South, A.P., Chaplain, M.A.: Mathematical modeling of cancer cell invasion of tissue: Biological insight from mathematical analysis and computational simulation. J. Math. Biol. 63(1), 141–71 (2011)
Arciero, J., Jackson, T., Kirschner, D.: A mathematical model of tumor- immune evasion and siRNA treatment. Discrete Continuous Dyn. Syst. Ser. B 4, 39–58 (2004)
Arlotti, L., Gamba, A., Lachowicz, M.: A kinetic model of tumor/immune system cellular interactions. J. Theor. Med. 4, 39–50 (2002)
Banerjee, S., Immunotherapy with Interleukin–2: A Study Based on Mathematical Modeling, Int. J. Appl. Math. Comput. Sci. 18(3), 389–398 (2008)
Bellomo, N., Delitala, M.: From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells. Phys. Life Rev. 5, 183–206 (2008)
Bellomo, N., Preziosi, L.: Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Math. Comput. Model. 32, 413–452 (2000)
Bellomo, N., Bellouquid, A., Delitala, M.: Mathematical topics on the modelling complex multicellular systems and tumor immune cells competition. Math. Models Methods Appl. Sci. 14, 1683–1733 (2004)
Bodnar, M., Forys, U.: Three types of simple DDEs describing tumor growth. J. Biol. Syst. 15, 453–471 (2007)
Burden, T., Ernstberger, J., Fister, K.R.: Optimal control applied to immunotherapy. Discrete Continuous Dyn. syst. 4, 135–146 (2004)
Caravagna, G., D’Onofrio, A., Milazzo, P., Barbuti, R.: Tumour suppression by immune system through stochastic oscillations. J. theor. biol. 265(3), 336–345 (2010)
Chang, Z., Song, J., Gao, G., Shen, Z.: Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Anticancer Drugs 22(6), 556–62 (2011)
Chaplain, M., Matzavinos, A.: Mathematical modelling of spatio-temporal phenomena in tumour immunology. In: Friedman, A. (ed.) Tutorials in Mathematical Biosciences III: Cell Cycle, Proliferation, and Cancer. Lecture Notes in Mathematics, vol. 1872, pp. 131–183. Springer, Berlin (2006)
De Angelis, E., Delitala, M., Marasco, A., Romano, A.: Bifurcation analysis for a mean field modelling of tumor and immune system competition. Math. Comput. Model. 37, 1131–1142 (2003)
Delitala, M.: Critical analysis and perspectives on kinetic (cellular) theory of immune competition. Math. Comput. Model. 35, 63–75 (2002)
de Pillis, L., Gu, W., Radunskaya, A.: Mixed immunotherapy and chemotherapy of tumors: Modeling, applications and biological interpretations. J. Theor. Biol. 238, 841–862 (2006)
D’Onofrio, A.: The role of the proliferation rate of effectors in the tumor-immune system competition. Math. Model. Meth. Appl. Sci. 16(8), 1375–1401 (2006)
d’Onofrio, A., Gatti, F., Cerrai, P., Freschi, L.: Delay-induced oscillatory dynamics of tumour–immune system interaction. Math. Comput. Model. 51, 572–591 (2010)
Forys, U.: Marchuks model of immune system dynamics with application to tumour growth. J. Theor. Med. 4, 85–93 (2002)
Friedman, A., Kim, Y.: Tumor cells proliferation and migration under the influence of their microenvironment. Math. Biosci. Eng. 8(2), 371–83 (2011)
Gabhann, F.M., Annex, B.H., Popel, A.S.: Gene therapy from the perspective of systems biology. Curr. Opin. Mol. Ther. 12(5), 570–577 (2010)
Gatenby, R.A., Maini, P.: Modelling a new angle on understanding cancer. Nature 420(6915), 462 (2002)
Gatenby, R.A., Maini, P.K.: Mathematical oncology: Cancer summed up. Nature 421(6921), 321 (2003)
Joshi, B., Wang, X., Banerjee, S., Tian, H., Matzavinos, A., Chaplain, M.A.: On immunotherapies and cancer vaccination protocols: A mathemati cal modelling approach. J. Theor. Biol. 259(4), 820–827 (2009)
Kelly, C., Leek, R., Byrne, H., Cox, S., Harris, A., Lewis, C.: Modelling macrophage infiltration into avascular tumours. J. Theor. Med. 4, 21–38 (2002)
Kirschner, D., Panetta, J.: Modeling immunotherapy of the tumor-immune interaction, J. Math. Biol. 37, 235–252 (1998)
Kirschner, D., Tsygvintsev, A.: On the global dynamics of a model for tumor immunotherapy. J. Math. Biosci. Eng. Vol. 6(3), 573–583 (2009)
Kronik, N., Kogan, Y., Vainstein, V., Agur, Z.: Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics. Cancer Immunol. Immunother. 57, 425–439 (2008)
Kuznetsov, V., Makalkyn, I., Taylor, M., Perelson, A.: Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, Bull. Math.Biol. 56(2), 295–321 (1994)
Macklin, P., McDougall, S., Anderson, A.R., Chaplain, M.A., Cristini, V., Lowengrub, J.: Multiscale modelling and nonlinear simulation of vascular tumour growth. J. Math. Biol. 58(4–5), 765–98 (2009)
Marino, S., Hogue, I.B., Ray, C.J., Kirschner, D.E.: A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254, 178–196 (2008) PMID:18572196
Matzavinos, A., Chaplain, M.: Travelling-wave analysis of a model of the immune response to cancer. C.R. Biol. 327, 995–1008 (2004)
Matzavinos, A., Chaplain, M., Kuznetsov, V.: Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour. IMA J. Math. Med. Biol. 21, 1–34 (2004)
McDougall, S.R., Anderson, A.R., Chaplain, M.A.: Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies. J. Theor. Biol. 241(3), 564–589 (2006)
McKay, M.D., Beckman, R.J., Conover, W.J.: A Comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21(2), 239–245 (1979)
Moscow, J.A., Cowan, K.H.: Biology of cancer. In: Goldman, L., Ausiello, D. (eds. Cecil. Med. 23rd edn. Saunders Elsevier, Philadelphia (2007), chap 187
Nana-Sinkam, S.P., Croce, C.M.: MicroRNAs as therapeutic targets in cancer. Transl. Res. 157(4), 216–225 (2011)
Owen, M., Sherratt, J.: Mathematical modelling of macrophage dynamics in tumours. Math. Model. Meth. Appl. Sci. 9, 513–539 (1999)
Owen, M.R., Alarcon, T., Maini, P.K., Byrne, H.M.: Angiogenesis and vascular remodelling in normal and cancerous tissues. J. Math. Biol. 58(4–5), 689–721 (2009)
Rabinowich, H., Banks, M., Reichert, T.E., Logan, T.F., Kirkwood, J.M., Whiteside, T.L.: Expression and activity of signaling molecules n T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Canc. Res. 2, 1263–1274 (1996)
Robbins, P.F., Morgan, R.A., Feldman, S.A., Yang, J.C., Sherry, R.M., Dudley, M.E., Wunderlich, J.R., Nahvi, A.V., Helman, L.J., Mackall, C.L., Kammula, U.S., Hughes, M.S., Restifo, N.P., Raffeld, M., Lee, C.-C.R., Levy, C.L., Li, Y.F., El-Gamil, M., Schwarz, S.L., Laurencot, C., Rosenberg, S.A.: Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917–924 (2011)
Rosenberg, S.A., Lotze, M.T.: Cancer immunotherapy using interleukin-2 and interleukin- 2-activated lymphocytes. Ann. Rev. Immunol. 4, 681–709 (1986)
Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., White, D.E.: Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271, 907–913 (1994)
Rosenstein, M., Ettinghousen, S.E., Rosenberg, S.A.: Extravasion of intravascular uid mediated by the systemic administration of recombinant interleukin 2. J. Immunol. 137, 1735–1742 (1986)
Sherratt, J., Perumpanani, A., Owen, M.: Pattern formation in cancer. In: Chaplain, M., Singh, G., McLachlan, J. (eds.) On Growth and Form: Spatio- temporal Pattern Formation in Biology. Wiley, New York (1999)
Szymanska, Z. (2003). Analysis of immunotherapy models in the context of cancer dynamics. Appl. Math. Comput. Sci. 13, 407–418.
Thun, M.J.: Biology of cancer. In: Goldman L, Ausiello D (eds.) Cecil. Med. 23rd edn. Saunders Elsevier, Philadelphia, Pa (2007), chap 185
Tran, K.Q., Zhou, J., Durflinger, K.H., et al.: Mini- mally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy. J. Immunother. 31, 742–751 (2008)
Webb, S., Sherratt, J., Fish, R.: Cells behaving badly: A theoretical model for the Fas/FasL system in tumour immunology. Math. Biosci. 179, 113–129 (2002)
Wu, F.T., Stefanini, M.O., Mac Gabhann, F., Kontos, C.D., Annex, B.H., Popel, A.S.: A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use. J. Cell Mol. Med. 14(3), 528–52 (2010)
Zhao, Y., Lam, D.H., Yang, J., Lin, J., Tham, C.K., Ng, W.H., Wang, S.: Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. Gene Therapy 19, 189–200 (2012)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tsygvintsev, A., Marino, S., Kirschner, D.E. (2013). A Mathematical Model of Gene Therapy for the Treatment of Cancer. In: Ledzewicz, U., Schättler, H., Friedman, A., Kashdan, E. (eds) Mathematical Methods and Models in Biomedicine. Lecture Notes on Mathematical Modelling in the Life Sciences. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4178-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4178-6_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4177-9
Online ISBN: 978-1-4614-4178-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)